PlainRecalls
FDA Drug Low Class III Terminated

Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09

Reported: February 12, 2020 Initiated: January 24, 2020 #D-0838-2020

Product Description

Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09

Reason for Recall

Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
4694 30x60-count bottles
Distribution
Nationwide
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India, NDA 33342-176-09. Recalled by Macleods Pharma Usa Inc. Units affected: 4694 30x60-count bottles.
Why was this product recalled?
Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 12, 2020. Severity: Low. Recall number: D-0838-2020.